SANUWAVE

SANUWAVE is an emerging leader in the **Biotechnology, Health Care, Manufacturing, and Medical Devices** industries. The company's slogan, **"Heal Wounds With Energy First,"** epitomizes its core mission. SANUWAVE specializes in the development and commercialization of energy transfer technology, offering a range of products designed to expedite wound healing on a cellular level. The **ENERGY FIRST** product portfolio represents the company's commitment to patient comfort and improved wound healing. By leveraging various energy waves, including shockwaves and ultrasound, SANUWAVE's products aim to activate the body’s natural regenerative process in a minimally to completely non-invasive manner. The **UltraMIST System** utilizes low-frequency ultrasound, while the **dermaPACE System** incorporates pulsed acoustic cellular expression (PACE®) technology, the first shockwave system FDA-cleared for the treatment of diabetic foot ulcers (DFU). SANUWAVE's value proposition extends beyond wound healing, recognizing the broader implications, such as improved patient quality of life and the prevention of complications that could lead to amputation or loss of life. The recent **Post-IPO Equity** investment on **18 October 2024** underscores the confidence investors have in SANUWAVE's innovative approach. As the company continues to advance its offerings, it remains at the forefront of leveraging energy-based solutions to address critical healthcare needs. For more information, please email: [email protected].